Table 3:
Secondary end pointsa
| Assessment | BMC (n = 315) | Matrix2 (n = 311) | Relative Risk (95% CI) | Difference (95% CI) | P Value |
|---|---|---|---|---|---|
| Angiographic assessment by core laboratory | |||||
| Modified Raymond Scale after procedure | |||||
| 1) Complete obliteration | 89 (35.6%) | 87 (36.6%) | 0.97 (0.77–1.23) | −1.0% (−9.5–7.6) | .9894 |
| 2) Residual neck/dog ear | 68 (27.2%) | 60 (25.2%) | 1.08 (0.80–1.45) | 2.0% (−5.8–9.8) | |
| 3) Residual aneurysm | 93 (37.2%) | 91 (38.2%) | 0.97 (0.77–1.22) | −1.0% (−9.6–7.6) | |
| Modified Raymond Scale at 455-day FU or re-intervention | |||||
| 1) Complete obliteration | 99 (39.9%) | 105 (44.3%) | 0.90 (0.73–1.11) | −4.4% (−13.2–4.4) | .8297 |
| 2) Residual neck/dog ear | 69 (27.8%) | 48 (20.3%) | 1.37 (1.00–1.90) | 7.6% (0.0–15.1) | |
| 3) Residual aneurysm | 80 (32.3%) | 84 (35.4%) | 0.91 (0.71–1.17) | −3.2% (−11.6–5.2) | |
| Aneurysm change | |||||
| Better | 81 (32.7%) | 60 (25.4%) | 1.28 (0.97–1.70) | 7.2% (−0.8–15.3) | .1225 |
| Same | 82 (33.1%) | 85 (36.0%) | 0.92 (0.72–1.17) | −3.0% (−11.4–5.5) | |
| Worse | 85 (34.3%) | 91 (38.6%) | 0.89 (0.70–1.13) | −4.3% (−12.9–4.3) | |
| Neurologic assessment | |||||
| Worseb mRS score | |||||
| At post-index procedure | 25 (8.5%) | 30 (10.5%) | 0.81 (0.49–1.35) | −2.0% (−6.7–2.8) | .4220 |
| At 455 days follow-upc | 33 (11.7%) | 28 (9.9%) | 1.19 (0.74–1.92) | 1.9% (−3.2–7.0) | .4705 |
| Technical success | |||||
| Technical procedure successd | 307 (97.5%) | 301 (96.8%) | 1.01 (0.98–1.03) | 0.7% (−1.9–3.3) | .6130 |
Note:—FU indicates follow-up.
a
Values are presented as mean ± SD for continuous variables and No. (%) for categoric variables. The denominator used for rates (%) can be smaller than the number of subjects in each group due to missing values.
b
Compared with the pre-index procedure.
c
All causes of deaths within 455 days were incorporated as a follow-up mRS score of 6.
d
Technical success evaluated at the patient level.